ELDN
Eledon Pharmaceuticals Inc
2.50$
+2.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -2.2% | +2.2% | -4.3% | +0.0% | +38.6% | +52.5% | +1.1% | -1.1% | +0.0% | -1.1% | +2.2% | +0.0% | +0.0% | +1.1% | +2.1% | -18.6% | +11.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -83.2% | -70.5% | +74.2% | -3.0% | -4.6% | +122.5% | +21.1% | +24.2% | +66.0% | +9.1% | -23.2% | -34.3% | -11.7% | +23.6% | -49.5% | -26.1% | +393.7% | +86.2% | -25.0% | +80.5% | -19.3% | +7.3% | -13.4% | +29.8% | -2.7% | +11.9% | -11.2% | +10.1% | -10.9% | +4.9% | +36.4% | +63.5% | +8.5% | -24.5% | +49.8% | -26.2% | +16.8% | -1.7% | +6.0% | – | |
| – | +383.0% | -66.7% | +576.9% | -60.1% | – | – | +9.5% | -0.6% | -0.6% | +2.7% | -5.0% | -21.3% | -31.5% | +78.9% | -26.6% | +194.0% | -11.0% | +0.9% | +11.2% | -23.6% | +12.5% | +0.7% | +9.8% | -11.1% | -11.3% | +7.4% | +5.2% | +3.6% | +0.1% | +5.7% | +27.1% | -9.2% | +69.6% | -34.5% | +0.5% | -8.0% | -2.6% | -0.2% | +16.4% | – | |
| – | +132.5% | -63.2% | +381.3% | -55.5% | -29.0% | +32.8% | +14.1% | +9.7% | +30.8% | +6.5% | -16.1% | -28.6% | +42.7% | -18.9% | -23.3% | +137.3% | +3.3% | +41.9% | -11.5% | +31.8% | -10.7% | +5.1% | -5.8% | +14.2% | +453.8% | -81.1% | -6.8% | +8.2% | -8.5% | +5.2% | +34.6% | +41.4% | +20.4% | -27.3% | +37.7% | -22.9% | +12.7% | -1.4% | +8.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -51.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.9% | +620.0% | +252.8% | +163.8% | +0.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -157.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -89.9% | +267.8% | -122.4% | – | – | – | – | – | -820.0% | – | – | – | – | – | -62.4% | +3.1% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -158.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -157.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.